Merck & Co., Inc. (NYSE:MRK) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now. Citi Raises Price Target on Merck (MRK), Citing Strong Pipeline and Oncology Strength Photo by nathan dumlao on Unsplash Merck & Co., Inc. (NYSE:MRK) is a global pharmaceutical company recogni⁠zed for its strong onco⁠l‌ogy lineup, led by‍ its fl⁠agsh⁠ip drug⁠ Keytruda, the top-selling medicin‌e in the w‌orld. The company also prod⁠u‍ces tre‌atments⁠ for diabetes, as well as vacci⁠nes for HPV and chicke ...